The sterile tubing welder market has seen considerable growth due to a variety of factors.
• The sterile tubing welder market has grown considerably in recent years. It is expected to grow from $2.34 billion in 2024 to $2.5 billion in 2025, with a CAGR of 7.2%.
This growth is supported by innovations in medical devices, rising demand for biopharmaceuticals, stringent regulatory standards, the increase in chronic diseases, and the globalization of healthcare.
The sterile tubing welder market is expected to maintain its strong growth trajectory in upcoming years.
• The sterile tubing welder market is projected to reach $3.26 billion by 2029, at a CAGR of 6.8%.
Growth is driven by the booming biotechnology and pharmaceutical industries, a focus on patient safety, the emergence of advanced materials, and the shift toward automation. Key trends include the adoption of single-use systems, the integration of robotics and automation, advancements in sterilization technologies, expansion of bioprocessing capabilities, and eco-friendly solutions.
The expansion of the biologics sector is anticipated to spur the growth of the sterile tubing welder market. Biologics, which are medical products originating from living organisms or their parts, include vaccines, blood components, gene therapies, tissues, and recombinant therapeutic proteins. This sector's expansion is stimulated by improvements in biotechnology and a more profound understanding of disease processes. Sterile tubing welders are used in creating biologics through aseptic connections, which are crucial in ensuring fluid transfer systems' integrity, a vital aspect in maintaining product purity. For example, the Food and Drug Administration (FDA) approved 55 new drugs in 2023, 29 of which were new chemical entities (NCEs) and 25 were new biological entities (NBEs), as reported by the National Library of Medicine in January 2024. This marked a 50% increase from 37 approvals in 2022, signifying the growing biologics sector's impact on the sterile tubing welder market's growth. Furthermore, an uptick in chronic disease prevalence is projected to further fuel the sterile tubing welder market's growth. Chronic diseases are health conditions that generally develop slowly, persist for prolonged periods, and often call for consistent medical management. Factors fuelling the increase in chronic diseases include ageing populations, unhealthy lifestyles such as poor diet, inactivity, and smoking, environmental factors, and refined detection and diagnosis. Sterile tubing welders are utilized in producing intravenous therapies and other sterile treatments for chronic diseases, ensuring delivery systems are free from contamination. For example, the National Centre for Biotechnology Information (NCBI) revealed in January 2023 that by 2050, the elderly population (50 years and older) suffering from at least one chronic disease is predicted to almost double, rising by 99.5% to hit 142.66 million. This anticipated increase in chronic diseases will also contribute to the growth of the sterile tubing welder market.
The sterile tubing welder market covered in this report is segmented –
1) By Mode: Manual, Automatic
2) By Application: Biopharmaceutical, Blood Processing, Diagnostic Laboratories, Other Applications
3) By End-Use: Hospitals, Research Clinics, Blood Centers, Other End-Users
Subsegments:
1) By Manual: Handheld Manual Sterile Tubing Welders, Bench-Top Manual Sterile Tubing Welders
2) By Automatic: Fully Automatic Sterile Tubing Welders, Semi-Automatic Sterile Tubing Welders
Key players in the sterile tubing welder market are stepping up the game by creating groundbreaking products such as genderless connectors. Such innovative tools streamline sterile connection and disconnection procedures, while upholding a high level of sterility in the manufacturing environment of biopharmaceuticals. These versatile, aseptic connectors are designed to expedite sterile connection and disconnection without the need for male or female specific parts. The recent move by the US-based firm, CPC (Colder Products Company), in June 2022 exemplifies this trend. It introduced the AseptiQuik G DC Series Connector, designed to amplify closed-system liquid processing for biopharmaceutical manufacturers. This genderless connector enables swift and aseptic connections and disconnections of tubing in non-sterile environments, eliminating the need for additional equipment.
Major companies operating in the sterile tubing welder market are:
• GE Healthcare
• Terumo BCT Inc.
• Sartorius AG
• Entegris Inc.
• Racer Technology
• LePure Biotech
• NewAge Industries
• GDM Electronics
• Bioengineering AG
• Biopharm Engineering
• Schunk Sonosystems
• Hangzhou Wu Zhou Medical Equipment
• Vesta Pharmaceuticals
• MGA Technologies
• Aseptic Group
• Sunbelt Technology
• Genesis BPS
• Biomen Biosystems Co. Ltd.
• Sentinel Process Systems Inc.
• AdvantaPure
North America was the largest region in the sterile tubing welder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile tubing welder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.